Skip to content
★ Sign in to follow
WW
Total declarations
25
Company
1
▲ Purchases (3 ops.)
€4.8M
▼ Sales (21 ops.)
€4.0M

Latest filing published 02 Dec 2009 for Biocryst Pharmaceuticals INC, €786k.

Insider track record

Disclosed buys
3
Disclosed sells
21
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

William W. Featheringill: trading record in brief

William W. Featheringill discloses dealings in Biocryst Pharmaceuticals Inc to SEC (Form 4). We count 25 filings; the first trade dates from 1 November 2000 and the latest from 1 December 2009.

Both buying and selling appear: 3 purchases worth €4.8M, against 21 sales worth €4.0M. Netting one side against the other leaves €847k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2009 alone, the filings show 2 purchases and 3 sales.

Half of the purchases are above €43k and half below.

The latest filing, published on 2 December 2009, reports an open-market sale of €786k in Biocryst Pharmaceuticals Inc. The most recent open-market purchase was published on 5 March 2009, 6,458 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to William W. Featheringill

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations